Earnings Call: NeoGenomics Sees Growth with NGS and New Test Launches
Daily NewsNeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, reported a strong financial performance in its third-quarter earni...
Read More